Singapore markets closed
Straits Times Index
3,240.58 +49.87 (+1.56%) Nikkei
26,739.03 +336.19 (+1.27%) Hang Seng
20,717.24 +596.56 (+2.96%) FTSE 100
7,389.98 +87.24 (+1.19%) BTC-USD
29,285.77 +59.08 (+0.20%) CMC Crypto 200
650.34 -23.03 (-3.42%)
BCRX Jan 2024 13.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 02:23PM EDT. Market open.
| Previous close | 2.6500 |
| Open | 2.3500 |
| Bid | 2.2000 |
| Ask | 2.9500 |
| Strike | 13.00 |
| Expiry date | 2024-01-19 |
| Day's range | 2.3500 - 2.3500 |
| Contract range | N/A |
| Volume | |
| Open interest | 903 |
- Motley Fool
Why BioCryst Stock Lost Nearly 4% of Its Value Today
The biotech whiffs on both revenue and profitability for its first quarter, and indicates more losses are in store.
- Motley Fool
BioCryst Pharmaceuticals (BCRX) Q1 2022 Earnings Call Transcript
Image source: The Motley Fool. BioCryst Pharmaceuticals (NASDAQ: BCRX)Q1 2022 Earnings CallMay 05, 2022, 8:30 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood day, and thank you for standing by.
- Zacks
BioCryst Pharmaceuticals (BCRX) Reports Q1 Loss, Lags Revenue Estimates
BioCryst (BCRX) delivered earnings and revenue surprises of -2.56% and 1.33%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
© 2022 Yahoo. All rights reserved.
